Search - tctmd.com

Displaying 681 - 700 of 768

Presentation TCT 2012

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

Presenter: Alfonso Ielasi, Azeem Latib, Marco Mussardo, Massimo Ferraro, Maria Angela Gullace, Cosmo Godino, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Antonio Colombo

January 03, 2012

Presentation TCT 2012

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Presenter: John Ormiston, William Wijns, Charlene Knape, Mathias Vrolix, James Stewart, Mark Webster, Robert Whitbourn, Alexandra Lansky, Hiram Bezzera, Peter Fitzgerald, David Kandzari

January 03, 2012

Presentation TCT 2012

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Presenter: Enno Boudriot, Holger Thiele, Franz J. Neumann, Michael Gick, Bruno Reichard, Peter Boekstegers, Harald Mudra, Florian Beier, Thomas Walther, Friedrich W. Mohr, Gerhard Schuler

January 03, 2012

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Conference News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

Advertisement

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Two New SES Show Improvement Over First-Generation Stents

Paclitaxel-coated balloon angioplasty demonstrates superior results

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

RAPID GENE: Validation of Point-of-Care Genetic Testing

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

ZES and SES Equally Effective in Long Lesion Treatment

Safety, Efficacy Reported with FIREHAWK SES

Polymer-free DES Shown Effective in Multiple Trials

Long-term Outcomes Improved with Biodegradable Biolimus-Eluting Stent vs. Permanent Polymer SES

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

EES Compared Favorably with SES In Two Pivotal Trials

ZES Match or Exceed Performance of Earlier DES

PAX Studies Highlight Polymer-Free DES Success

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content